Our blog

The Funding Dilemma: Does Bigger Always Mean Better in Life Sciences?
The Funding Dilemma: Does Bigger Always Mean Better in Life Sciences?
by Andrew Maddison
Posted in Life Science & Diagnostics
The question of funding size success has become increasingly relevant. Is the amount of funding always the key to breakthrough discoveries? Katie Davis explores the impact of funding size on research, development, and commercialization in the life science industry.
Read more
Biotech & Biopharma Funding Roundup and Key Findings | July
Biotech & Biopharma Funding Roundup and Key Findings | July
by Andrew Maddison
Posted in Biopharma, Life Science & Diagnostics
In this blog, we explore the latest updates throughout the month of July. You can subscribe to Katies biotech funding updates over on LinkedIn to keep up to date with the ever-growing biotech market.
Read more
Biotech Funding Rounds and Key Findings for June
Biotech Funding Rounds and Key Findings for June
by Andrew Maddison
Posted in Biopharma, Life Science & Diagnostics
In this blog, we explore the latest updates throughout the month of June. You can subscribe to Katies biotech funding updates over on LinkedIn to keep up to date with the ever-growing biotech market.
Read more